CRISPR Delivery: NIH Fuels 2026 Gene Therapy Boom
NIH funds $150M for new CRISPR delivery methods. See how viral and non-viral systems improve gene editing, making therapies safer and more effective.
Investors often misprice the Fed's terminal rate. Understand 2026 guidance, dot plots, and regional speeches to forecast interest rates.
Gene Editing Policy: $1.5B at Stake in 2026